Biological Psychiatry Global Open ScienceMolecular BiologyPeer-reviewed journal article
Autism-associated PTCHD1 missense variants bind to the SNARE-associated protein, SNAPIN, but exhibit impaired subcellular trafficking
Stephen F. PastoreiD, Connie T. Y. Xie, Roya Derwish, Tahir MuhammadiD, Tereza BLÁHOVÁ, Sierra C. El-masri, Paul W. FranklandiD, Paul A. HameliD, John B. VincentiD
Abstract
BackgroundPatched domain-containing 1 (PTCHD1) is a susceptibility gene for autism spectrum disorder and intellectual disability. Its function in brain development and neurotransmission remains elusive. Studies have sought to characterize PTCHD1 function by elucidating its neural network of interacting proteins. However, given the current paucity of functional information, many PTCHD1 missense variants in clinical databases are classified as variants of uncertain significance (VUSs), severely limiting the healthcare resources available to patients and families. MethodsA yeast two-hybrid assay was used to identify synaptic PTCHD1-interacting proteins. Candidate binding partners were validated by cloning; transient over-expression in HEK293T cells, followed by co-immunoprecipitation and immunoblotting; and immunocytochemistry in differentiated P19 cells. To evaluate the pathogenicity of clinical missense variants, site-directed mutagenesis was employed, followed by transient over-expression and immunocytochemistry in non-neuronal (HEK293T) and neuronal (Neuro-2A cells) systems. ResultsA novel interaction was identified between the first lumenal loop of PTCHD1 and the SNARE-associated protein SNAPIN, which is implicated in synaptic vesicle exocytosis. Clinically associated missense variants within this region did not disrupt SNAPIN binding, indicating that the pathoetiology of these variants is unrelated to this interaction. However, six of the 12 missense variants tested exhibited pronounced retention within the endoplasmic reticulum, and impaired neuronal and non-neuronal trafficking to the plasma membrane. ConclusionsThese data yield insights regarding the role of PTCHD1 in neurodevelopment and neurotransmission, and suggest a neuropathological mechanism for missense variants. These findings provide a platform for diagnostic assay and VUS interpretation, allowing for clinical re-classification of these variants.
- Citations
- 2
- FWCI
- 1.18
- Field percentile
- top 26%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nonsynonymous Mutations in Intellectual Disability and Autism Spectrum Disorder Gene PTCHD1 Disrupt N-Glycosylation and Reduce Protein Stability
Connie T. Y. Xie, Stephen F. Pastore, … Paul A. Hamel·CellsPeer-reviewed·Jan 21, 2024
- Heterozygous and homozygous variants in STX1A cause a neurodevelopmental disorder with or without epilepsy
Johannes Luppe, Heinrich Sticht, … Konrad Platzer·European Journal of Human GeneticsPeer-reviewed·Dec 23, 2022
- Delineation of the pathogenic presynaptic mechanisms of synaptotagmin-1 variants
Holly Melland, Kyla Venter, … Sarah L. Gordon·bioRxiv·Oct 29, 2023
- Adaptive functions correlate with evoked neurotransmitter release in SYT1-associated neurodevelopmental disorder
Paul Yangho Park, Lauren E. Bleakley, … Sarah L. Gordon·bioRxiv·Nov 25, 2023
- Regulation of spontaneous neurotransmission and homeostatic synaptic plasticity by synaptotagmin-1 disease variants at the SNARE primary interface.
Elena D. Bagatelas, Ok‐Ho Shin, … Ege T. Kavalali·bioRxiv·Feb 18, 2026
- Non-syndromic autism-associated SCN2A variants selectively exert dominant-negative effects on NaV1.2 channels.
Sandrine Cestèle, Renzo Guerrini, … Massimo Mantegazza·bioRxiv·Feb 25, 2026